glp-1 medication risks compounding pharmacies FDA Intensifies Crackdown on Compounding Pharmacies & GLP-1 Medicine:

GLP-1 medications can help by reducing appetite and cravings, making it easier to maintain the calorie deficit needed for fat loss

But lately, they have leaned more heavily into directing their marketing efforts to women in menopause

Specifically, increased utilization of Ozempic and Wegovy (semaglutide) as well as Mounjaro and Zepbound (tirzepatide) have contributed substantially to recent growth

These drugs marked a significant step forward in what was possible for weight management with medication

Interested in GIP-based therapies or dual/triple agonist peptides

There's still a lot of work to do, however, to improve public health in the US and around the world, where obesity rates remain high: 28 percent as reported in the UK in 2022, and 31.7 percent in Australia in 2022-23